This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Khamzina, L. Articles by Marette, A. Search for Related Content PubMed PubMed Citation Articles by Khamzina, L. Articles by Marette, A.

Increased Activation of the Mammalian Target of Rapamycin Pathway in Liver and Skeletal Muscle of Obese Rats: Possible Involvement in Obesity-Linked Insulin Resistance

Department of Anatomy and Physiology and Lipid Research Unit, Laval University Hospital Research Center, Ste-Foy, Québec, Canada G1V 4G2

Address all correspondence and requests for reprints to: Dr. André Marette, Department of Physiology and Lipid Research Unit, Laval University Hospital Research Center, 2705 Laurier boulevard, Ste-Foy, Québec, Canada G1V 4G2. E-mail: andre.marette{at}crchul.ulaval.ca.

The mammalian target of rapamycin (mTOR) pathway integrates insulin and nutrient signaling in numerous cell types. Recent studies also suggest that this pathway negatively modulates insulin signaling to phosphatidylinositol 3-kinase/Akt in adipose and muscle cells. However, it is still unclear whether activation of the mTOR pathway is increased in obesity and if it could be involved in the promotion of insulin resistance. In this paper we show that basal (fasting state) activation of mTOR and its downstream target S6K1 is markedly elevated in liver and skeletal muscle of obese rats fed a high fat diet compared with chow-fed, lean controls. Time-course studies also revealed that mTOR and S6K1 activation by insulin was accelerated in tissues of obese rats, in association with increased inhibitory phosphorylation of insulin receptor substrate-1 (IRS-1) on Ser⁶³⁶/Ser⁶³⁹ and impaired Akt activation. The relationship between mTOR/S6K1 overactivation and impaired insulin signaling to Akt was also examined in hepatic cells in vitro. Insulin caused a time-dependent activation of mTOR and S6K1 in HepG2 cells. This was associated with increased IRS-1 phosphorylation on Ser⁶³⁶/Ser⁶³⁹. Inhibition of mTOR/S6K1 by rapamycin blunted insulininduced Ser⁶³⁶/Ser⁶³⁹ phosphorylation of IRS-1, leading to a rapid (5 min) and persistent increase in IRS-1-associated phosphatidylinositol 3-kinase activity and Akt phosphorylation. These results show that activation of the mTOR pathway is increased in liver and muscle of high fat-fed obese rats. In vitro studies with rapamycin suggest that mTOR/S6K1 overactivation contributes to elevated serine phosphorylation of IRS-1, leading to impaired insulin signaling to Akt in liver and muscle of this dietary model of obesity.

This article has been cited by other articles:

				D. Cota, E. K. Matter, S. C. Woods, and R. J. Seeley The Role of Hypothalamic Mammalian Target of Rapamycin Complex 1 Signaling in Diet-Induced Obesity J. Neurosci., July 9, 2008; 28(28): 7202 - 7208. [Abstract] [Full Text] [PDF]

				Z. Szocs, B. Brunmair, K. Stadlbauer, P. Nowotny, L. Bauer, A. Luger, and C. Furnsinn Age-Dependent Development of Metabolic Derangement and Effects of Intervention with Pioglitazone in Zucker Diabetic Fatty Rats J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 323 - 329. [Abstract] [Full Text] [PDF]

				M. J. Zhu, B. Han, J. Tong, C. Ma, J. M. Kimzey, K. R. Underwood, Y. Xiao, B. W. Hess, S. P. Ford, P. W. Nathanielsz, et al. AMP-activated protein kinase signalling pathways are down regulated and skeletal muscle development impaired in fetuses of obese, over-nourished sheep J. Physiol., May 15, 2008; 586(10): 2651 - 2664. [Abstract] [Full Text] [PDF]

				M. Fraenkel, M. Ketzinel-Gilad, Y. Ariav, O. Pappo, M. Karaca, J. Castel, M.-F. Berthault, C. Magnan, E. Cerasi, N. Kaiser, et al. mTOR Inhibition by Rapamycin Prevents {beta}-Cell Adaptation to Hyperglycemia and Exacerbates the Metabolic State in Type 2 Diabetes Diabetes, April 1, 2008; 57(4): 945 - 957. [Abstract] [Full Text] [PDF]

				C. M. Maya-Monteiro, P. E. Almeida, H. D'Avila, A. S. Martins, A. P. Rezende, H. Castro-Faria-Neto, and P. T. Bozza Leptin Induces Macrophage Lipid Body Formation by a Phosphatidylinositol 3-Kinase- and Mammalian Target of Rapamycin-dependent Mechanism J. Biol. Chem., January 25, 2008; 283(4): 2203 - 2210. [Abstract] [Full Text] [PDF]

				M. Garcia-San Frutos, T. Fernandez-Agullo, A. J. De Solis, A. Andres, C. Arribas, J. M. Carrascosa, and M. Ros Impaired Central Insulin Response in Aged Wistar Rats: Role of Adiposity Endocrinology, November 1, 2007; 148(11): 5238 - 5247. [Abstract] [Full Text] [PDF]

				M. F. Gregor and G. S. Hotamisligil Thematic review series: Adipocyte Biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease J. Lipid Res., September 1, 2007; 48(9): 1905 - 1914. [Abstract] [Full Text] [PDF]

				F. Tremblay, S. Brule, S. Hee Um, Y. Li, K. Masuda, M. Roden, X. J. Sun, M. Krebs, R. D. Polakiewicz, G. Thomas, et al. Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance PNAS, August 28, 2007; 104(35): 14056 - 14061. [Abstract] [Full Text] [PDF]

				M. Krebs, B. Brunmair, A. Brehm, M. Artwohl, J. Szendroedi, P. Nowotny, E. Roth, C. Furnsinn, M. Promintzer, C. Anderwald, et al. The Mammalian Target of Rapamycin Pathway Regulates Nutrient-Sensitive Glucose Uptake in Man Diabetes, June 1, 2007; 56(6): 1600 - 1607. [Abstract] [Full Text] [PDF]

				M. Doi, I. Yamaoka, M. Nakayama, K. Sugahara, and F. Yoshizawa Hypoglycemic effect of isoleucine involves increased muscle glucose uptake and whole body glucose oxidation and decreased hepatic gluconeogenesis Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1683 - E1693. [Abstract] [Full Text] [PDF]

				B. Draznin Molecular Mechanisms of Insulin Resistance: Serine Phosphorylation of Insulin Receptor Substrate-1 and Increased Expression of p85{alpha}: The Two Sides of a Coin. Diabetes, August 1, 2006; 55(8): 2392 - 2397. [Abstract] [Full Text] [PDF]

				D. Cota, K. Proulx, K. A. B. Smith, S. C. Kozma, G. Thomas, S. C. Woods, and R. J. Seeley Hypothalamic mTOR signaling regulates food intake. Science, May 12, 2006; 312(5775): 927 - 930. [Abstract] [Full Text] [PDF]

				I. G. Poornima, P. Parikh, and R. P. Shannon Diabetic Cardiomyopathy: The Search for a Unifying Hypothesis Circ. Res., March 17, 2006; 98(5): 596 - 605. [Abstract] [Full Text] [PDF]

				G. S. Hotamisligil Role of Endoplasmic Reticulum Stress and c-Jun NH2-Terminal Kinase Pathways in Inflammation and Origin of Obesity and Diabetes Diabetes, December 1, 2005; 54(suppl_2): S73 - S78. [Abstract] [Full Text] [PDF]